WallStSmart
SLDB

Solid Biosciences LLC

NASDAQ: SLDB · HEALTHCARE · BIOTECHNOLOGY

$7.26
+2.98% today

Updated 2026-04-30

Market cap
$733.18M
P/E ratio
P/S ratio
3.65x
EPS (TTM)
$-1.99
Dividend yield
52W range
$2 – $9
Volume
1.3M

Solid Biosciences LLC (SLDB) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+13.7%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+47.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-9.0%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-18.3%
2025-11-03
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-20$-0.53-1.8%$7.12$7.14+0.3%
2025-11-03$-0.48+31.4%$5.39$4.41-18.3%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.52$-0.53-1.8%
2025-09-30$-0.70$-0.48+31.4%
2025-06-30$-0.64$-0.42+34.4%
2025-03-31$-0.54$-0.59-9.1%
2024-12-31$-0.78$-1.00-27.8%$3.12M-34.0%
2024-09-30$-0.67$-0.79-17.9%
2024-06-30$-0.65$-0.61+6.2%
2024-03-31$-0.64$-0.64+0.0%
2023-12-31$-0.99$-1.00-1.0%$4.74M
2023-09-30$-1.19$-1.05+11.8%
2023-06-30$-1.53$-1.25+18.3%
2023-03-31$-2.05$-1.50+26.8%

Frequently asked questions

Has Solid Biosciences LLC beaten earnings estimates?
Solid Biosciences LLC has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +13.7% over the last 4 quarters.
How does SLDB stock react to earnings?
SLDB stock has moved an average of -9.0% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.